NSCLC Cell Line - Search Videos

Platinum-Based Chemo Doublets: Backbone for NSCLC Treatment | CancerGRACE

cancergrace.org

Platinum-Based Chemo Doublets: Backbone for NSCLC Treatment | CancerGRACE

Dr. Jack West, Swedish Cancer Institute, identifies the platinum-based chemotherapy doublet as the backbone of first-line treatment for the majority of NSCLC patients.

Non-small-cell lung cancer Lung Cancer Treatment

ROS1 and Lung Cancer

ROS1 and Lung Cancer

Chemotherapy for lung cancer

Chemotherapy for lung cancer

cancerresearchuk.org

Lung Cancer Stages and Survival Rate

Lung Cancer Stages and Survival Rate

cancercenter.com

Top videos

NSCLC Oncogenic Driver Mutations: Where Do We Stand? - Advances in NSCLC

NSCLC Oncogenic Driver Mutations: Where Do We Stand? - Advances in NSCLC

medpagetoday.com

Unmet Needs in NSCLC Treatment | AJMC

Unmet Needs in NSCLC Treatment | AJMC

Dr. Massarelli on First-Line ALK NSCLC Treatment | OncLive

Dr. Massarelli on First-Line ALK NSCLC Treatment | OncLive

Non-small-cell lung cancer Lung Cancer Symptoms

NTRK and Lung Cancer

NTRK and Lung Cancer

Radiation Therapy for Lung Cancer

Radiation Therapy for Lung Cancer

Lung Cancer: My Journey

Lung Cancer: My Journey

NSCLC Oncogenic Driver Mutations: Where Do We Stand? - Advances in NSCLC

NSCLC Oncogenic Driver Mutations: Where Do We Stand? - Advances i…

medpagetoday.com

Unmet Needs in NSCLC Treatment | AJMC

Unmet Needs in NSCLC Treatment | AJMC

Dr. Massarelli on First-Line ALK NSCLC Treatment | OncLive

Dr. Massarelli on First-Line ALK NSCLC Treatment | OncLive

Options in Second-Line Non-Squamous NSCLC | OncLive

Options in Second-Line Non-Squamous NSCLC | OncLive

KRAS G12C-Mutated NSCLC: Current Treatment Paradigms | OncLive

KRAS G12C-Mutated NSCLC: Current Treatment Paradigms | On…

Selecting Treatment for First- Line Non-Squamous NSCLC | OncLive

Selecting Treatment for First- Line Non-Squamous NSCLC | OncLive

First-, Second-, and Third-Line Treatment for NSCLC | OncLive

First-, Second-, and Third-Line Treatment for NSCLC | OncLive

Second-Line Metastatic NSCLC: Treatment Landscape and Challen…

Dr. Pacheco on Second-Line Therapy for ALK NSCLC | OncLive

Upfront Use of Second-Line Agents in ALK NSCLC | OncLive

Dr Joshua Sabari Discusses Amivantamab’s First-Line Approv…

Dr. Levy on First-Line Treatment for Nondriver NSCLC | OncLive

NSCLC Care: Evaluating Durvalumab in the First-Line Setting

Testing Methodologies and Standards in Metastatic NSCLC | …

Testing for ALK Rearrangements in Advanced NSCLC | OncLive

Guideline recommendations for first-line treatment of advanced N…

When to Conduct Molecular Testing in NSCLC | OncLive

Dr Cooper on Considerations to Help Guide ADC Use in Second-Li…

Combination Therapy: A New Frontline Standard in the Treatme…

Durvalumab ± Tremelimumab Chemotherapy in First-Line Metast…

NSCLC & Targeted Therapy: A Brief Overview and Update in the Metas…

1.2K viewsDec 13, 2023

Dr. Wakelee on Nintedanib Plus Chemotherapy in NSCLC | OncLive

Guidelines-recommended targeted therapies as second-line treatmen…

Dr. Langer Discusses the Use of NGS in NSCLC | OncLive

Amivantamab Plus Chemotherapy vs Chemotherapy as First-line Tre…

PD-L1 Testing in NSCLC: A Practical Guide for Oncologists | OncLive

NSCLC Case Study 2: A Never-Smoker with Neuroendocrine Mar…

Insights from COCOON: Prophylactic Dermatologic Manag…

targetedonc.com

Resectable Early-Stage NSCLC: How the Standard of Care Is Evolv…

See more videos